J1171
HCPCSInj, hydromorphone, 0.1 mg
Official HCPCS Level II long descriptor
Injection, hydromorphone, 0.1 mg
HCPCS Level II code J1171 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, hydromorphone, 0.1 mg
Added to HCPCS: 2024-10-01
Nearby codes in J1
- J1110Inj dihydroergotamine mesylt
- J1120Acetazolamid sodium injectio
- J1130Inj diclofenac sodium 0.5mg
- J1160Digoxin injection
- J1162Digoxin immune fab (ovine)
- J1163Inj, diltiazem hcl, 0.5 mg
- J1164Inj diltiazem in 0.72% nacl
- J1165Phenytoin sodium injection
- J1180Dyphylline injection
- J1190Dexrazoxane hcl injection
- J1200Diphenhydramine hcl injectio
- J1201Inj. cetirizine hcl 0.5mg
- J1202Miglustat oral 65 mg
- J1203Inj, cipaglucosidase, 5 mg
- J1205Chlorothiazide sodium inj
- J1212Dimethyl sulfoxide 50% 50 ml
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.